Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, UBS Group Analyst Says

Veeva Systems (NYSE:VEEV) had its price target increased by stock analysts at UBS Group from $190.00 to $290.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the technology company’s stock. UBS Group’s price target points to a potential upside of 0.37% from the company’s current price.

A number of other analysts have also issued reports on the company. Wall Street Zen lowered Veeva Systems from a “buy” rating to a “hold” rating in a research report on Monday, August 3rd. Piper Sandler began coverage on Veeva Systems in a report on Monday. They set an “overweight” rating and a $295.00 price objective on the stock. Morgan Stanley increased their target price on Veeva Systems from $215.00 to $275.00 and gave the company an “equal weight” rating in a research note on Thursday. Royal Bank Of Canada raised their price target on shares of Veeva Systems from $275.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Guggenheim upped their price target on shares of Veeva Systems from $276.00 to $310.00 and gave the company a “buy” rating in a report on Thursday. Nineteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $270.25.

Veeva Systems Stock Performance

Shares of VEEV stock traded up $44.03 on Thursday, hitting $288.94. The stock had a trading volume of 2,059,033 shares, compared to its average volume of 2,447,631. The stock’s 50 day moving average is $203.41 and its 200-day moving average is $183.04. The firm has a market capitalization of $46.94 billion, a price-to-earnings ratio of 51.46, a P/E/G ratio of 1.06 and a beta of 0.92. Veeva Systems has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.13. The firm had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The firm’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Equities analysts expect that Veeva Systems will post 6.65 earnings per share for the current year.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the sale, the insider directly owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. This represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.

Institutional Investors Weigh In On Veeva Systems

A number of institutional investors have recently modified their holdings of VEEV. Empire Life Investments Inc. grew its stake in shares of Veeva Systems by 21.1% in the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock worth $8,272,000 after purchasing an additional 6,453 shares during the last quarter. Czech National Bank acquired a new stake in Veeva Systems during the second quarter valued at approximately $7,584,000. BNP Paribas boosted its holdings in Veeva Systems by 89.3% during the fourth quarter. BNP Paribas now owns 19,239 shares of the technology company’s stock worth $4,308,000 after buying an additional 9,077 shares in the last quarter. ABN Amro Investment Solutions boosted its holdings in Veeva Systems by 28.4% during the fourth quarter. ABN Amro Investment Solutions now owns 76,809 shares of the technology company’s stock worth $17,146,000 after buying an additional 17,007 shares in the last quarter. Finally, AustralianSuper Pty Ltd bought a new stake in Veeva Systems during the fourth quarter worth approximately $2,453,000. Institutional investors own 88.20% of the company’s stock.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, while EPS of $2.35 exceeded the $2.22 analyst consensus. Subscription revenue increased 16% to $766.8 million. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Management issued fiscal Q3 revenue guidance of approximately $932 million-$935 million and EPS guidance of $2.33-$2.34, both above Wall Street expectations. Full-year fiscal 2027 EPS guidance of $9.21 and revenue guidance of about $3.7 billion also exceeded consensus estimates. Veeva Q2 2027 Earnings Call Transcript
• Positive Sentiment: Executives highlighted continued strength in Vault CRM, targeting more than 70% market share, and said the first Falcon customer deployments are expected this year. AI-related capabilities are also contributing to demand and revenue growth. Veeva CRM and Falcon Update
• Positive Sentiment: Needham reaffirmed its Buy rating, while Piper Sandler initiated coverage, adding favorable analyst attention following the earnings release. Needham Reaffirms Buy Rating
• Neutral Sentiment: Analyst commentary emphasized Veeva’s combination of recurring growth, strong margins and financial strength, but the stock’s elevated valuation—around 44 times earnings—leaves less room for execution or guidance disappointments.
• Negative Sentiment: The modest decline in the shares despite the earnings and guidance beats suggests investors may be taking profits or were already pricing in strong results. Near-term sentiment could remain sensitive to valuation and the pace of new product adoption.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.